Cargando…
Semi-allogeneic vaccines and tumor-induced immune tolerance
Experimental results from studies with inbred mice and their syngeneic tumors indicated that the inoculation of semi-allogeneic cell hybrids (derived from the fusion between syngeneic tumor cells and an allogeneic cell line) protects the animal host from a subsequent lethal challenge with unmodified...
Autores principales: | Yu, Jin, Kindy, Mark S, Gattoni-Celli, Sebastiano |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631475/ https://www.ncbi.nlm.nih.gov/pubmed/19133135 http://dx.doi.org/10.1186/1479-5876-7-3 |
Ejemplares similares
-
Semi-allogeneic vaccine for T-cell lymphoma
por: Yu, Jin, et al.
Publicado: (2007) -
Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine
por: Gattoni-Celli, Sebastiano, et al.
Publicado: (2016) -
A therapeutic cancer vaccine against GL261 murine glioma
por: Kindy, Mark S., et al.
Publicado: (2016) -
Vitamin D binding protein polymorphisms significantly impact vitamin D status in children
por: Newton, Danforth A., et al.
Publicado: (2019) -
Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
por: Schneidawind, Dominik, et al.
Publicado: (2020)